Stocktoria

CBAK Energy Technology, Inc. CBAT

CBAK Energy Technology, Inc. (CBAT) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $195.2M at a -4.8% net margin.

Chart by TradingView
27/100
Stocktoria Quality Score · grade D
3/9
Piotroski F — financial health
-2.78
Altman Z″ — distress risk · distress
Dividend yield · no dividend
-2.32
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
1 4 4 2 5 3 3 4 6 3 2016201720182019202020212022202320242025
Altman Z″
-6.63 -5.75 -6.81 -8.64 -4.48 -0.62 -1.77 -1.08 -2.78 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$0.79 as of 2026-08-01 · -15.3% 1y
$0.50$1.0252-wk

Beneish M-score: -2.32 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$53M
Net margin 5y avg22.7%
Beta1.27
Employees1,739

Analyst price target

$1.50 +90.4% vs last
· 1 analysts
target range $1.50 – $1.50

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 27%
Net marginstronger than 46%
Return on equitystronger than 50%
Revenue growthstronger than 65%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 3/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets-0.28
Retained earnings / assets-0.314
EBIT / assets-0.043
Equity / liabilities0.356

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
CBATCBAK Energy Technology, Inc.3/9-2.78+10.5%
ULBIULTRALIFE CORP5/92.86+16.2%
NRGVEnergy Vault Holdings, Inc.4/9-7.28+340.9%
BYRNByrna Technologies Inc.3/96.4313.4+37.7%
EOSEEos Energy Enterprises, Inc.6/9-8.45+631.8%
GAUZGauzy Ltd.5/9-6.34+32.8%
BLNKBlink Charging Co.3/9-18%

All Manufacturing companies →

About CBAK Energy Technology, Inc.

CBAK Energy Technology Limited, together with its subsidiaries, manufactures, commercializes, and distributes lithium-ion and sodium-ion rechargeable batteries. The company operates through the CBAK and Hitrans segments. It develops and manufactures nickel-cobalt-manganese precursor materials and cathode materials. It also provides battery systems and integration solutions for electric vehicles and energy storage applications. Its products are used in electric cars, buses, hybrid vehicles, electric bicycles, tricycles, and other mobility applications, as well as in energy storage systems including residential supply and power supply applications. The company supports applications in logistics vehicles, commercial vehicles, and light electric mobility, and supplies battery solutions for both transportation and stationary energy storage use cases. CBAK Energy Technology Limited was founded in 2001 and is based in Dalian, China, and serves markets in China and international regions.

FAQ

Is CBAT financially healthy?

CBAK Energy Technology, Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does CBAT pay a dividend?

No, CBAK Energy Technology, Inc. does not currently pay a dividend.

How profitable is CBAT?

In FY2025, CBAK Energy Technology, Inc. had a net margin of -4.8% and a return on equity of -8.3%.

What is the analyst price target for CBAT?

The average Wall-Street price target for CBAK Energy Technology, Inc. is $1.50, about 90.4% above the recent price, from 1 analysts.

Is CBAT a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on CBAK Energy Technology, Inc.: a Piotroski F-score of 3/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.